Wednesday, July 8, 2026

Drug profile · INN

telavancin hydrochloride

telavancin hydrochloride (VIBATIV) is a cell outer membrane inhibitor. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 8
Pipeline programs 0
News articles 0
Drug details — telavancin hydrochloride
US status
approved
Class
Route
INTRAVENOUS
Patents
8
Programs
0
Data quality
0.89

Quick answer

telavancin hydrochloride (VIBATIV) is a cell outer membrane inhibitor. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN telavancin hydrochloride
Brand VIBATIV
Mechanism Cell outer membrane inhibitor
Target Cell outer membrane
Route INTRAVENOUS
Formulation POWDER

Mechanism of action

Cell outer membrane inhibitor

Primary target: Cell outer membrane

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. colistin sulfate Cell outer membrane inhibitor
  2. polymyxin b sulfate Cell outer membrane inhibitor
  1. US 12161632

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 10925860

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 10583126

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 10314824

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 10016399

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9693998

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7531623

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 6727286

    Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid

    Expires Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is telavancin hydrochloride?

telavancin hydrochloride (VIBATIV) is a cell outer membrane inhibitor. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for telavancin hydrochloride?

VIBATIV is a marketed brand name for telavancin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of telavancin hydrochloride?

telavancin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.